Cannabidiol oil's effects on blood measurements in rats with experimentally generated leukemia. | ||||
| Bulletin of Faculty of Science, Zagazig University | ||||
| Article 19, Volume 2024, Issue 2, July 2024, Page 182-188 PDF (732.08 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/bfszu.2023.245111.1333 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Sarah mohamed Alashqar  1; Nabil A. Soliman2
| ||||
| 1zoology, faculty of Science, Zagazig University | ||||
| 2Physiology departement Faculty of science Zagazig university Egypt | ||||
| Abstract | ||||
| Background: Background: Within a few weeks of application, the chemical carcinogen 7,12 dimethyl benzaanthracene ( DMBA ) causes the development of carcinomas. For pharmaceutical purposes, natural medicines (Cannabinoid), (CBD) made from plant extracts have continued to be produced. Production of all-natural, less dangerous anticarcinogenic compounds that have the potential to lessen the challenges given by neoplastic diseases like leukemic cancer. Aim of the study:- Examination of the antioxidant activity of CBD in male albino rats that were injected with DMBA. Method:- This experiment was conducted on 30 male rats sectioned into 6 groups with 5 each, Group1 (control), Group2 ( olive oil), Group3 ( cannabinoid), Group 4 ( leukemic), Group5 (prophylactic), Group 6 (Treated). Result Compared to the leukemic rat group, both the prophylactic and the CBD-treated groups. CBD was successful in returning normal levels of total white blood cells (WBC), lymphocytes, red blood cells (RBCs), haemoglobin (Hb), platelets, granulocytes, and spleen tissue. Conclusion:- Our results elucidate the ability of CBD to heal the damage caused by the toxicity effect of DMBA in the blood. | ||||
| Keywords | ||||
| leukemia 7; 12 dimethyl benzaanthracene (DMBA); Cannabinoid (CBD); and blood picture | ||||
|
Statistics Article View: 164 PDF Download: 267 |
||||
